Clinical trial

Boosted Lexiva With Lovaza Adjunctive Therapy in Hypertriglyceridemic, HIV-Infected Subjects

NCT01010399

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2009-09-01

PhasePHASE4

Study timeline

Study start (unknown)2009-09-01Date precision: month

Registry last updated2012-04-18

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Hypertriglyceridemiaunresolved

HIV Infectionunresolved

Interventions

LovazaDIETARY_SUPPLEMENT

fosamprenavir/ritonavirDRUG

Sponsors & collaborators

Felizarta, Franco, M.D.lead sponsor

GlaxoSmithKlinecollaborator

Mapped research locations

BakersfieldCalifornia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01010399 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.